What Is Liothyronine (T3)? Dosage, Half-Life & How to Track It

What liothyronine is and how it works

Your thyroid gland normally produces both T4 and T3, with T4 acting mostly as a reservoir that peripheral tissues convert into the more biologically active T3 as needed. Liothyronine is synthetic T3 itself — no conversion step required — which is why it acts faster and more directly on metabolic rate than levothyroxine (T4) does.

It is FDA-approved under the brand Cytomel for hypothyroidism, myxedema, and as a diagnostic tool (the T3 suppression test). Outside that clinical use, it gets used off-label — usually alongside a calorie deficit and sometimes alongside AAS or a GLP-1 — specifically to push metabolic rate up during a cutting phase, trading real thyroid-axis risk for a faster metabolism.

Every cell that has a thyroid hormone receptor is a target, which is the double-edged part: raising T3 raises metabolic rate, but it also raises heart rate, affects bone turnover, and — critically — signals your pituitary to produce less TSH, which tells your own thyroid to produce less hormone. Exogenous T3 does not add to your natural output; over time, it replaces it.

Typical dosing & half-life

At a roughly 25-hour serum half-life (the Cytomel label separately lists a longer ~2.5-day biological half-life, reflecting tissue-level activity), liothyronine clears meaningfully faster than levothyroxine, which is part of why replacement doses are sometimes split into two smaller doses across the day rather than taken all at once — smoother levels, fewer symptoms tied to the peak.

Replacement doses for genuine hypothyroidism are modest; off-label protocols are typically lower still to start, with slow increases and — the part most often skipped — an equally slow taper back down rather than stopping abruptly.

These reflect commonly reported ranges, not a recommendation — thyroid hormone dosing is not a one-size number, and both the start and the taper matter as much as the peak dose.

The HPT axis & why tapering off matters

The hypothalamic-pituitary-thyroid (HPT) axis works on a feedback loop: your hypothalamus and pituitary sense circulating thyroid hormone and adjust TSH up or down to keep your own thyroid producing the right amount. Add exogenous T3, and that feedback loop reads it the same as your own gland working — TSH falls, and your thyroid’s natural output falls with it.

Stop abruptly after any meaningful stretch of use and there is a real gap: your own thyroid has been producing less, and it does not resume full output instantly. That gap is what produces the crash — fatigue, cold intolerance, brain fog, weight regain — that people sometimes describe after stopping T3 cold. A gradual taper, the same principle as a steroid PCT, is what avoids it.

What to monitor & the real risks

A TSH and free T3/free T4 panel before starting establishes your baseline, and repeating it periodically is how you catch either under- or over-replacement before it becomes symptomatic — TSH suppressed near zero while on T3 is expected and not itself an emergency, but it is the number that tells you the axis is actively suppressed.

Overuse symptoms mirror hyperthyroidism: elevated resting heart rate, palpitations, anxiety, heat intolerance, and — with sustained high doses — accelerated bone turnover that can affect bone density over time. Resting heart rate is the simplest early-warning sign available day to day, well before a lab draw.

It’s worth stating plainly: liothyronine is not indicated for obesity or weight loss. Thyroid hormone prescribing information carries a class warning that doses beyond replacement need do not produce additional weight loss and instead risk serious, potentially life-threatening cardiac toxicity, particularly arrhythmias — a risk that compounds meaningfully when T3 is paired with a sympathomimetic stimulant like clenbuterol, since both independently raise heart rate and cardiac workload.

Frequently asked questions